FIXX Annual SG&A
$31.26 M
-$6.88 M-18.04%
01 December 2023
Summary:
As of January 21, 2025, FIXX annual selling, general & administrative expenses is $31.26 million, with the most recent change of -$6.88 million (-18.04%) on December 1, 2023. During the last 3 years, it has fallen by -$1.32 million (-4.04%).FIXX Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
FIXX Quarterly SG&A
$7.90 M
+$1.06 M+15.48%
01 December 2023
Summary:
As of January 21, 2025, FIXX quarterly selling, general & administrative expenses is $7.90 million, with the most recent change of +$1.06 million (+15.48%) on December 1, 2023. Over the past year, it has increased by +$1.06 million (+15.48%).FIXX Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
FIXX TTM SG&A
-$2.02 B
-$112.96 M-5.93%
01 December 2023
Summary:
As of January 21, 2025, FIXX TTM selling, general & administrative expenses is -$2.02 billion, with the most recent change of -$112.96 million (-5.93%) on December 1, 2023. Over the past year, it has dropped by -$2.05 billion (-6509.38%).FIXX TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
FIXX Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -18.0% | +15.5% | -6509.4% |
| 3 y3 years | -4.0% | +15.5% | -6509.4% |
| 5 y5 years | +80.7% | +15.5% | -6509.4% |
FIXX Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | -18.0% | -44.2% | -4870.9% |
Homology Medicines Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | $31.26 M(-18.0%) | $7.90 M(+15.5%) | $31.26 M(-0.8%) |
| Sept 2023 | - | $6.84 M(-16.4%) | $31.50 M(-3.0%) |
| June 2023 | - | $8.19 M(-1.6%) | $32.47 M(+0.5%) |
| Mar 2023 | - | $8.32 M(+2.2%) | $32.32 M(-15.3%) |
| Dec 2022 | $38.14 M(+3.5%) | $8.15 M(+4.3%) | $38.14 M(-6.5%) |
| Sept 2022 | - | $7.81 M(-2.8%) | $40.77 M(-1.3%) |
| June 2022 | - | $8.03 M(-43.2%) | $41.31 M(-2.4%) |
| Mar 2022 | - | $14.15 M(+31.2%) | $42.32 M(+14.9%) |
| Dec 2021 | $36.84 M(+13.1%) | $10.78 M(+29.1%) | $36.84 M(+9.5%) |
| Sept 2021 | - | $8.35 M(-7.6%) | $33.64 M(-0.2%) |
| June 2021 | - | $9.04 M(+4.4%) | $33.71 M(+0.7%) |
| Mar 2021 | - | $8.66 M(+14.2%) | $33.46 M(+2.7%) |
| Dec 2020 | $32.57 M | $7.59 M(-9.9%) | $32.57 M(+5.9%) |
| Sept 2020 | - | $8.42 M(-4.2%) | $30.77 M(+8.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2020 | - | $8.79 M(+13.2%) | $28.38 M(+13.0%) |
| Mar 2020 | - | $7.77 M(+34.4%) | $25.13 M(+13.1%) |
| Dec 2019 | $22.21 M(+28.4%) | $5.78 M(-4.3%) | $22.21 M(+3.2%) |
| Sept 2019 | - | $6.04 M(+9.0%) | $21.52 M(+11.4%) |
| June 2019 | - | $5.54 M(+14.0%) | $19.32 M(+5.5%) |
| Mar 2019 | - | $4.86 M(-4.5%) | $18.31 M(+6.0%) |
| Dec 2018 | $17.30 M(+109.0%) | $5.09 M(+32.4%) | $17.29 M(+16.1%) |
| Sept 2018 | - | $3.84 M(-15.1%) | $14.88 M(+16.7%) |
| June 2018 | - | $4.53 M(+18.3%) | $12.76 M(+24.9%) |
| Mar 2018 | - | $3.83 M(+42.5%) | $10.21 M(+23.4%) |
| Dec 2017 | $8.28 M(+92.3%) | $2.69 M(+56.3%) | $8.28 M(+48.0%) |
| Sept 2017 | - | $1.72 M(-13.3%) | $5.59 M(+44.3%) |
| June 2017 | - | $1.98 M(+4.7%) | $3.87 M(+104.7%) |
| Mar 2017 | - | $1.89 M | $1.89 M |
| Dec 2016 | $4.30 M | - | - |
FAQ
- What is Homology Medicines annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Homology Medicines?
- What is Homology Medicines annual SG&A year-on-year change?
- What is Homology Medicines quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Homology Medicines?
- What is Homology Medicines quarterly SG&A year-on-year change?
- What is Homology Medicines TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Homology Medicines?
- What is Homology Medicines TTM SG&A year-on-year change?
What is Homology Medicines annual selling, general & administrative expenses?
The current annual SG&A of FIXX is $31.26 M
What is the all time high annual SG&A for Homology Medicines?
Homology Medicines all-time high annual selling, general & administrative expenses is $38.14 M
What is Homology Medicines annual SG&A year-on-year change?
Over the past year, FIXX annual selling, general & administrative expenses has changed by -$6.88 M (-18.04%)
What is Homology Medicines quarterly selling, general & administrative expenses?
The current quarterly SG&A of FIXX is $7.90 M
What is the all time high quarterly SG&A for Homology Medicines?
Homology Medicines all-time high quarterly selling, general & administrative expenses is $14.15 M
What is Homology Medicines quarterly SG&A year-on-year change?
Over the past year, FIXX quarterly selling, general & administrative expenses has changed by +$1.06 M (+15.48%)
What is Homology Medicines TTM selling, general & administrative expenses?
The current TTM SG&A of FIXX is -$2.02 B
What is the all time high TTM SG&A for Homology Medicines?
Homology Medicines all-time high TTM selling, general & administrative expenses is $42.32 M
What is Homology Medicines TTM SG&A year-on-year change?
Over the past year, FIXX TTM selling, general & administrative expenses has changed by -$2.05 B (-6509.38%)